US › Healthcare

Jupiter Neurosciences, Inc. Common Stock (JUNS)

US · Healthcare · Biotechnology

$0.10+3.60%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$18,652

Net profit

$-2.1M

Profit YoY

-34.9%

EPS

$-0.06

Net margin

-11,054.9%

Key statistics

Market cap

$5.1M

Forward P/E

7.0

P/B

227.66

Book value

$-0.08

EPS (TTM)

$-0.26

52-week high

$1.84

52-week low

$0.08

50-day MA

$0.21

200-day MA

$0.66

Analyst view

Analysts rate Jupiter Neurosciences, Inc. Common Stock a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $30.00.

Shareholding

Insiders

32.34%

Institutions

3.37%

Largest institutional holders

Fund	Stake
Vestor Capital Partners	2.01%
Vanguard Capital Management, LLC	0.75%
Geode Capital Management, LLC	0.44%
Yorkville Advisors Global, LP	0.27%
Citadel Advisors Llc	0.21%
Vanguard Fiduciary Trust Co	0.18%
Northern Trust Corp	0.05%
Virtu Financial LLC	0.03%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Jupiter Neurosciences, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.